193 related articles for article (PubMed ID: 32258534)
1. Post-transplant malignancies in alcoholic liver disease.
Singh A; De A; Singh V
Transl Gastroenterol Hepatol; 2020; 5():30. PubMed ID: 32258534
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.
Mukthinuthalapati PK; Gotur R; Ghabril M
World J Hepatol; 2016 Apr; 8(12):533-44. PubMed ID: 27134701
[TBL] [Abstract][Full Text] [Related]
3. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.
Chak E; Saab S
Liver Int; 2010 Oct; 30(9):1247-58. PubMed ID: 20602682
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis.
Duvoux C; Delacroix I; Richardet JP; Roudot-Thoraval F; Métreau JM; Fagniez PL; Dhumeaux D; Cherqui D
Transplantation; 1999 Feb; 67(3):418-21. PubMed ID: 10030289
[TBL] [Abstract][Full Text] [Related]
8. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes associated with alcohol relapse after liver transplantation.
Lim J; Curry MP; Sundaram V
World J Hepatol; 2017 Jun; 9(17):771-780. PubMed ID: 28660011
[TBL] [Abstract][Full Text] [Related]
10.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
11. Management of alcohol recurrence before and after liver transplantation.
Marroni CA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S109-14. PubMed ID: 26193869
[TBL] [Abstract][Full Text] [Related]
12. The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
Modaresi Esfeh J; Hanouneh IA; Dalal D; Tabba A; Lopez R; Pagadala M; Eghtesad B; Zein NN
Int J Organ Transplant Med; 2012; 3(4):157-63. PubMed ID: 25013641
[TBL] [Abstract][Full Text] [Related]
13. Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.
Jiménez-Romero C; Justo-Alonso I; Cambra-Molero F; Calvo-Pulido J; García-Sesma Á; Abradelo-Usera M; Caso-Maestro O; Manrique-Municio A
World J Hepatol; 2015 May; 7(7):942-53. PubMed ID: 25954477
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907
[TBL] [Abstract][Full Text] [Related]
15. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
17. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
[TBL] [Abstract][Full Text] [Related]
18. Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.
Obed A; Stern S; Jarrad A; Lorf T
World J Gastroenterol; 2015 Apr; 21(14):4423-6. PubMed ID: 25892898
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
[TBL] [Abstract][Full Text] [Related]
20. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
